NATIONAL TUBERCULOSIS AND LEPROSY — Strip Importer Profile
Pharmaceutical Importer · #9 buyer for Strip · $1.1M import value · 22 shipments · NIGERIA · DGFT Verified
NATIONAL TUBERCULOSIS AND LEPROSY is the #9 importer of Strip from India with $1.1M in import value and 22 verified shipments. NATIONAL TUBERCULOSIS AND LEPROSY holds a 0.6% market share in Strip imports based in NIGERIA. The company sources from 2 verified suppliers across 4 formulations shipped to 1 country. Overall, NATIONAL TUBERCULOSIS AND LEPROSY imports 8 pharmaceutical products worth $13.7M across 3 therapeutic categories.
NATIONAL TUBERCULOSIS AND LEPROSY — Strip Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Strip to NATIONAL TUBERCULOSIS AND LEPROSY?
Verified from 22 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SVIZERA LABS PRIVATE LIMITED | $600.0K | 12 | 54.5% |
| MANEESH PHARMACEUTICALS LIMITED | $500.0K | 10 | 45.5% |
NATIONAL TUBERCULOSIS AND LEPROSY sources Strip from 2 verified Indian suppliers based on 22 customs records. The primary supplier is SVIZERA LABS PRIVATE LIMITED accounting for 54.5% of imports.
How Does NATIONAL TUBERCULOSIS AND LEPROSY Compare to Nearest Strip Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 16 | M/S. RANBAXY FARMACEUTICA LTDA : | BRAZIL | $2.0M | 64 | $31.3K |
| 20 | M/S. PLANET PHARMA | FRANCE | $2.0M | 111 | $17.8K |
| 9 | NATIONAL TUBERCULOSIS AND LEPROSY ★ | NIGERIA | $1.1M | 22 | $50.0K |
| 18 | DR LABARAN SHEHU | NIGERIA | $1.1M | 21 | $50.0K |
| 4 | XXISSXXLOBXX TRXXE DXXC | CHINA | $700.0K | 14 | $50.0K |
NATIONAL TUBERCULOSIS AND LEPROSY ranks #9 among 2,109 Strip importers from India. Average shipment value of $50.0K compared to the market average of $26.2K. The closest competitors by value are M/S. RANBAXY FARMACEUTICA LTDA : and M/S. PLANET PHARMA.
Where Does NATIONAL TUBERCULOSIS AND LEPROSY Import Strip To?
Destination countries from 22 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| NIGERIA | $1.1M | 22 | 100.0% |
NATIONAL TUBERCULOSIS AND LEPROSY imports Strip to 1 country. The primary destination is NIGERIA receiving 100.0% of shipments worth $1.1M.
What Strip Formulations Does NATIONAL TUBERCULOSIS AND LEPROSY Import?
| Formulation | Value | Shipments |
|---|---|---|
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS(6431X12) | $300.0K | 6 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150MG/ISONIAZID 75 MG/ PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(6431X6) | $300.0K | 6 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPIC | $250.0K | 5 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICI | $250.0K | 5 |
NATIONAL TUBERCULOSIS AND LEPROSY imports 4 distinct Strip formulations from India. The top formulation is 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID with 6 shipments worth $300.0K.
Regulatory Requirements: Importing Strip into Nigeria
What NATIONAL TUBERCULOSIS AND LEPROSY and other importers must comply with to import Strip from India
Regulatory Authority
National Agency for Food and Drug Administration and Control (NAFDAC)
Approval Process for Generic Strip
Drug registration under NAFDAC guidelines. Requires quality data, stability studies, and WHO-type Certificate of Pharmaceutical Product (CPP) from India.
Typical timeline: 6–18 months
GMP Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Import Licence & Documentation
NAFDAC import permit; Certificate of Pharmaceutical Product (CPP) from CDSCO India
Labeling & Packaging
English language labeling; NAFDAC registration number required
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified inspections of Indian sites in recent years.
Regulatory information is provided for general reference based on publicly available NAFDAC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with NAFDAC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Strip from India and How Much Does NATIONAL TUBERCULOSIS AND LEPROSY Import?
India exported $55.3M worth of Strip through 15,000 shipments from 612 suppliers to 170 countries, serving 2,109 buyers globally. NATIONAL TUBERCULOSIS AND LEPROSY imports $1.1M of this total, accounting for 0.6% of India's Strip exports with 22 shipments from NIGERIA. This is verified from 22 customs shipment records covering 4 distinct formulations.
What Is the Average Order Value for NATIONAL TUBERCULOSIS AND LEPROSY's Strip Imports?
NATIONAL TUBERCULOSIS AND LEPROSY's average Strip order value is $50.0K per consignment, based on 22 shipments totaling $1.1M. NATIONAL TUBERCULOSIS AND LEPROSY is based in NIGERIA and ranks #9 among all Strip importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Strip to NATIONAL TUBERCULOSIS AND LEPROSY?
NATIONAL TUBERCULOSIS AND LEPROSY sources Strip from 2 verified Indian suppliers: SVIZERA LABS PRIVATE LIMITED ($600.0K, 54.5%), MANEESH PHARMACEUTICALS LIMITED ($500.0K, 45.5%). This is based on 22 customs records.
How Does NATIONAL TUBERCULOSIS AND LEPROSY Compare to Other Strip Importers?
NATIONAL TUBERCULOSIS AND LEPROSY ranks #9 among 2,109 Strip importers from India with a 0.6% market share. The top 3 importers are YUSEN LOGISTICS BENELUX BELGIUM ($16.4M), AO RANBAXY ($9.7M), AO "RANBAXY" ($5.8M). NATIONAL TUBERCULOSIS AND LEPROSY processed 22 shipments from NIGERIA.
What Other Medical Devices & Diagnostics Products Does NATIONAL TUBERCULOSIS AND LEPROSY Import?
NATIONAL TUBERCULOSIS AND LEPROSY also imports these medical devices & diagnostics products. Each links to the detailed product page.
About NATIONAL TUBERCULOSIS AND LEPROSY
NATIONAL TUBERCULOSIS AND LEPROSY imports 8 products worth $13.7M. Beyond Strip, top products include Rifampicin, Isoniazid, Kit, Ethambutol, Pyrazinamide. View the complete NATIONAL TUBERCULOSIS AND LEPROSY profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Strip — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Strip shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NATIONAL TUBERCULOSIS AND LEPROSY matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NATIONAL TUBERCULOSIS AND LEPROSY's capped import value divided by total capped export value for Strip across all Indian exporters.
- 5.Verified Records: This page is backed by 22 individual customs records matching NATIONAL TUBERCULOSIS AND LEPROSY importing Strip, covering 4 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 170+ countries, 2,109+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Strip Import Data for NATIONAL TUBERCULOSIS AND LEPROSY
Access order-level details, pricing data, supplier connections, and competitive analysis for NATIONAL TUBERCULOSIS AND LEPROSY's Strip imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NATIONAL TUBERCULOSIS AND LEPROSY
Full Company Profile →
8 products · $13.7M total trade · 3 categories
NATIONAL TUBERCULOSIS AND LEPROSY × Strip
Verified from customs records
Company Overview
Top Products by NATIONAL TUBERCULOSIS AND LEPROSY
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NATIONAL TUBERCULOSIS AND LEPROSY.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Strip. For current order-level data, contact TransData Nexus.